Jamal Mosallam

Chief Financial Officer at Simon Group Holdings

Jamal Mosallam has a diverse work experience spanning over two decades. Jamal started their career as an International Banking Officer at Comerica Bank in 1996 and later joined Visteon Corporation as a Senior Financial Analyst in 2000. In 2004, they became a Financial Controller at Thermo Fisher Scientific.

In 2008, Jamal joined AlJomaih Automotive Company as a Corporate Financial Controller and was eventually promoted to direct and steer Western Province dealership operations. Jamal also served as the interim CFO during their tenure.

Jamal then worked at Jaidah Group as a Chief Operating Officer and Chief Financial Officer from 2011 to 2019. Jamal was responsible for growing profit levels, increasing cash flow, and supporting organizational restructuring.

Jamal joined Ocuphire Pharma in 2020 as an Interim Chief Financial Officer, where they finalized a $20 million financing and reverse merger with a NASDAQ listed Pharmaceutical company.

From 2020 to 2022, Jamal served as the Chief Financial Officer at United Exports Sales and Marketing, Americas, a company specializing in the fresh fruit industry.

In 2022, they joined Upkara, a start-up focused on biopreservation technology, as their Chief Financial Officer. They developed a patented platform capable of stabilizing complex biological materials.

Currently, Jamal works as the Chief Financial Officer at Simon Group Holdings, a company investing in people and ideas that drive innovation.

Jamal Mosallam's education history includes attending Columbia Business School, although no specific degree or field of study is provided. Jamal also attended Wayne State University, but no details about the degree or field of study are mentioned. In terms of additional certifications, Jamal obtained a CEPA certification from the Exit Planning Institute in 2019. Furthermore, they acquired several certifications from Columbia Business School Executive Education in 2023, including Mergers and Acquisitions, Developing and Leading High-Performance Teams, VC Due Diligence, VC Decision Making, and the Venture Capital Private Equity Senior Executive Program. Jamal also completed the Cambridge Startup Funding: Pre-Seed to Exit Programme from the University of Cambridge in 2022.

Links

Previous companies

Thermo Fisher Scientific logo
Ocuphire Pharma logo
Visteon logo
Comerica logo

Timeline

  • Chief Financial Officer

    September, 2023 - present